Compare ACRS & HVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACRS | HVT |
|---|---|---|
| Founded | 2012 | 1885 |
| Country | United States | United States |
| Employees | N/A | 2392 |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 311.0M | 336.7M |
| IPO Year | 2015 | N/A |
| Metric | ACRS | HVT |
|---|---|---|
| Price | $4.54 | $21.77 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $10.20 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 71.4K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 6.05% |
| EPS Growth | ★ 69.01 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,683,000.00 | N/A |
| Revenue This Year | N/A | $8.83 |
| Revenue Next Year | $4.24 | $8.70 |
| P/E Ratio | ★ N/A | $22.08 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.22 | $19.32 |
| 52 Week High | $5.15 | $27.67 |
| Indicator | ACRS | HVT |
|---|---|---|
| Relative Strength Index (RSI) | 53.18 | 54.10 |
| Support Level | $4.08 | $21.97 |
| Resistance Level | $5.02 | $23.58 |
| Average True Range (ATR) | 0.26 | 1.09 |
| MACD | -0.06 | 0.08 |
| Stochastic Oscillator | 38.04 | 70.07 |
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.
Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of revenue from its upholstery products and, secondarily, from bedroom furniture.